SCMP.com
Shares in Jiangsu Hengrui Pharmaceuticals, China’s largest drug maker by market value, got a boost on Thursday after it announced its fifth licensing deal of the year, widening its access to the key emerging market of India.
The Shanghai-listed company, which went public in Hong Kong in May and raised HK$9.9 billion (US$1.26 billion…
Read More
China’s Hengrui gets boost from fifth drug-licensing deal of year
Tama Mayoral
11:21
Shares in Jiangsu Hengrui Pharmaceuticals, China’s largest drug maker by market value, got a boost on Thursday after it announced its fifth licensing deal of the year, widening its access to the key emerging market of India. The Shanghai-listed company, which went public in Hong Kong in May and raised HK$9.9 billion (US$1.26 billion…
